AzTrials
AzTrials

Digital Eye StrainDESIROUSNCT05675475

Study of the Association Between Digital Eye Syndrome With Binocular Vision and the Ocular Surface in Higher Education Students in the Area of Health Technologies

An observational study of Digital Eye Strain, run by Universidade Nova de Lisboa at 1 site in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to determinate the association between DES and changes in binocular vision and ocular surface. in higher education students in the area of health technologies. Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
Conditions the study is for
Digital Eye Strain
What is being tested?
Exposure, Orthoptic assessment (Outcome measure) and Tear film Break Up Time (BUT) test (Outcome measure)
How many people
400 participants
Where
1 sitePortugal
Study dates
Jan 2023to Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Higher Education Students in the Area of Health Technologies.

Who may be able to join

  • Students of the first, second and third year of the degrees offered by Lisbon School of Health Technology, Instituto Politécnico de Lisboa;
  • Age between 18 to 39 years;
  • Accept and sign the consent.

Who cannot join

  • Working Students;
  • Students with known binocular vision disorders;
  • Previous eye surgeries.

Trial locations and contacts

1 site in 1 country.

Maria Barata, MSc contact

d52905@alunos.uevora.pt

Portugal1 site
  • Escola Superior de Tecnologia de Saúde de Lisboa

    Lisbon, 1990-096

    Carla Lança, PhD, +351218980421, carla.costa@estesl.ipl.pt

    Maria Barata, MSc, d52905@alunos.uevora.pt

Other trials in Portugal

About this study

The goal of this observational study is to determinate the association between DES and changes in binocular vision and ocular surface. in higher education students in the area of health technologies. The main questions it aims to determine the prevalence of Digital Eye Syndrome (DES); the association between DES and changes in binocular vision and ocular surface; whether the time of use and the type of electronic devices influences the degree and type of symptoms of DES; and to determine whether there is an association between the type of ametropia and the symptoms of DES. Participants will have to answer 3 questionnaires (the Computer Vision Syndrome Questionnaire; the Convergence Insufficiency Symptoms Survey, and the Dry Eye Questionnaire (DEQ-5)) and then they will perform an orthoptic assessment and an assessment of the ocular surface with the tear film Break Up Time (BUT) test.

Being tested
Exposure, Orthoptic assessment (Outcome measure), Tear film Break Up Time (BUT) test (Outcome measure)
Keywords
accommodation, convergence, tear film

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExposureOther

    Higher education students from health technologies field exposed to digital devices.

  • Orthoptic assessment (Outcome measure)Diagnostic test

    The orthoptic assessment is a non-invasive assessment that will last for 30 min to determine visual parameters related to binocular vision. It will be carried out by the research team in the orthoptics and vision sciences laboratories of the Lisbon School of Health Tecnology.

  • Tear film Break Up Time (BUT) test (Outcome measure)Diagnostic test

    The BUT test is a tear film rupture assessment test that allows the stability of the tear film to be evaluated. To perform these tests, it is necessary to instill fluorescein and then it is observed in the slit lamp under illumination with a cobalt blue filter, to count the break-up time.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of Digital Eye Syndrome

    To verify the existence or absence of digital fatigue syndrome in higher education students. For this purpose, the Computer Vision Syndrome Questionnaire will be used. To verify the existence or not of digital fatigue syndrome in higher education. The Computer Vision Syndrome Questionnaire (CVS-Q) will be applied, which is composed of 16 x 2 questions, to assess the symptoms and their intensity. This questionnaire makes it possible to classifying CVS as asymptomatic and symptomatic.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

Secondary outcomes (16)
  1. Convergence Insufficiency Symptoms Survey

    The main objective of this questionnaire is to assess the frequency of symptoms of visual discomfort and consists of fifteen questions. The answers to the questions are evaluated and allow classifying binocular vision into "norm", "suspected convergence insufficiency" and "convergence insufficiency".

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  2. Dry Eye Questionnaire (DEQ-5)

    The DEQ-5 questionnaire is the reduced version of the DEQ questionnaire that allows the assessment of dry eye. this questionnaire is made up of 5 questions and allows to obtain an answer score that classifies as "normal" and "dry eye".

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  3. Far Visual Acuity

    Visual acuity is the spatial resolution capability of the visual system. The unit of measurement for this variable will be the minimum resolution angle algorithm (LogMAR).

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  4. Near Visual Acuity

    Visual acuity is the spatial resolution capability of the visual system. The unit of measurement for this variable will be the minimum resolution angle algorithm (LogMAR).

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  5. Far Cover Test

    The cover test is one of the variables used to study the motor component of the visual system and is a categorical variable, which will allow the identification of latent and manifest ocular deviations.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  6. Near Cover Test

    The cover test is one of the variables used to study the motor component of the visual system and is a categorical variable, which will allow the identification of latent and manifest ocular deviations.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  7. Near Stereopsis

    Stereopsis is one of the binocular vision parameters and the measurement unit used will be the arc seconds.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  8. Near Point of Convergence

    The near point of convergence is one of the convergence assessment methods and the unit of measurement is cm.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  9. Flexibility of Accommodation

    The flexibility of accommodation is one of the accommodation evaluation parameters and its measurement unit is cycle per minute.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  10. Amplitude of Accommodation

    The amplitude of accomodation is one of the accommodation evaluation parameters and its measurement unit is diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  11. Far Convergence

    The far convergence is one of the elements of fusional vergencies and its measurement unit is the prismatic diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  12. Near Convergence

    The near convergence is one of the elements of fusional vergencies and its measurement unit is the prismatic diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  13. Near Divergence

    The near divergence is one of the elements of fusional vergencies and its measurement unit is the prismatic diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  14. Far Divergence

    The far divergence is one of the elements of fusional vergencies and its measurement unit is the prismatic diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  15. Break Up Time Test

    The BUT Test will allow assessing the stability of the tear film and the unit of measurement will be seconds.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

  16. Refrative Error

    The refractive error will be assessed using the auto refratometer and your measurements will be in diopters.

    Measured: Immediately after subject enrollment, up to 1 week (single point collection)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2023
  2. Study startJan 2023 (estimated)
  3. Primary completionJun 2023 (estimated)
  4. Study completionJun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05675475
Sponsor's protocol ID
DESIROUS
Acronym
DESIROUS
Status last verified
Dec 2022
First submitted
12 Dec 2022
Last updated
9 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Digital Eye Strain, run by Universidade Nova de Lisboa at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Carla Lança, PhD (+351218980421, carla.costa@estesl.ipl.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of Digital Eye Syndrome (time frame: Immediately after subject enrollment, up to 1 week (single point collection)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in